Código Oficial de Georgia Anotado

Título 31. HEALTH · Capítulo 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Artículo 1. RIGHT TO TRY

31-52-7. Coverage under health benefit plan permitted but not required.

Vigente

Actualizado hasta: Including Acts of the 2025 Session of the General Assembly of Georgia.

El texto siguiente es la ley tal como la imprime el estado, en inglés.

A health benefit plan or governmental agency may provide coverage for the cost of any investigational drug, biological product, or device pursuant to this article; provided, however, that nothing in this article shall be construed to require a health benefit plan or governmental agency to provide coverage for the cost of any investigational drug, biological product, or device pursuant to this article.

Las notas siguientes se imprimen con la sección, pero no son ley promulgada (O.C.G.A. § 1-1-1(c)). Se muestran aparte del texto.

History

Code 1981, § 31-52-7, enacted by Ga. L. 2016, p. 345, § 1/HB 34; Ga. L. 2025, p. 455, § 3/SB 72, effective July 1, 2025.

Amendments

The 2025 amendment, effective July 1, 2025, substituted “article” for “chapter” in three places in this Code section.

Editor's notes

Ga. L. 2025, p. 455, § 1/SB 72, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Hope for Georgia Patients Act.’”

Leer la página oficial (el PDF del estado, abierto en la página de la que se leyó este texto).

Actualizado hasta: Including Acts of the 2025 Session of the General Assembly of Georgia.

Texto leído de t31-(v23)-2025-pdf.pdf, Volumen V23, edición 2025, página 1090; acción de fusión: bound only; SHA-256 del archivo ba5a57f85d04.